LEADER 05376nam 2200661 450 001 9910464188103321 005 20200520144314.0 010 $a1-61705-223-X 035 $a(CKB)2670000000599026 035 $a(EBL)1969452 035 $a(SSID)ssj0001438961 035 $a(PQKBManifestationID)12550558 035 $a(PQKBTitleCode)TC0001438961 035 $a(PQKBWorkID)11379182 035 $a(PQKB)10848914 035 $a(MiAaPQ)EBC1969452 035 $a(Au-PeEL)EBL1969452 035 $a(CaPaEBR)ebr11026056 035 $a(OCoLC)904138399 035 $a(EXLCZ)992670000000599026 100 $a20150317h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTumor board review $eguideline and case reviews in oncology /$fRobert F. Todd [and four others], editors 205 $aSecond edition. 210 1$aNew York, New York :$cDemos Medical,$d2015. 210 4$dİ2015 215 $a1 online resource (449 p.) 300 $aDescription based upon print version of record. 311 $a1-62070-060-3 311 $a1-336-02912-9 320 $aIncludes bibliographical references and index. 327 $aCover; Title; Copyright; Contents; Contributors; Preface to the Second Edition; Preface to the First Edition; Share Tumor Board Review: Guideline and Case Reviews in Oncology, Second Edition; Chapter 1: Head and Neck Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Overview of Staging; Site-Specific Staging for SCCHN; Case Summaries; Locoregionally Advanced Disease; Evidence-Based Case Discussion; Recurrent/Metastatic SCCHN; Evidence-Based Case Discussion; Summary; Review Questions; References; Chapter 2: Thyroid Cancer 327 $aEpidemiology, Risk Factors, Natural History, and PathologyDifferentiated Thyroid Carcinoma; Staging; Case Summaries; Early-Stage Papillary Thyroid Cancer: Stage I; Evidence-Based Case Discussion; Differentiated Follicular Thyroid Cancer: Late-Stage Follicular Thyroid Cancer; Evidence-Based Case Discussion; Medullary Thyroid Cancer; Evidence-Based Case Discussion; Anaplastic Thyroid Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 3: Non-Small-Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Early-Stage NSCLC 327 $aEvidence-Based Case DiscussionSurgery and Adjuvant Chemotherapy in Early-Stage NSCLC; Regional (Stage III) NSCLC; Evidence-Based Case Discussion; Metastatic NSCLC, Case 1; Evidence-Based Case Discussion; Metastatic NSCLC, Case 2; Evidence-Based Case Discussion; Recurrent NSCLC; Evidence-Based Case Discussion; Review Questions; References; Chapter 4: Small Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; LS-SCLC: Combined Modality Therapy; Evidence-Based Case Discussion; ES-SCLC: Systemic Palliative Therapy; Evidence-Based Case Discussion 327 $aReview QuestionsReferences; Chapter 5: Breast Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Ductal Carcinoma In Situ; Early-Stage ER+ Breast Cancer; Early-Stage ER+ Breast Cancer, Stage I or II; Early-Stage TNBC; Locally Advanced HER2+ Breast Cancer; Metastatic Breast Cancer; A Special Note on Breast Cancer in Pregnancy; Review Questions; References; Chapter 6: Esophageal Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Locally Advanced Resectable Esophageal Cancer; Evidence-Based Case Discussion 327 $aLocally Advanced Unresectable Esophageal CancerEvidence-Based Case Discussion; Metastatic Esophageal Cancer; Evidence-Based Case Discussion; Acknowledgment; Review Questions; References; Chapter 7: Gastric Cancer; Epidemiology, Natural History, Risk Factors, and Pathology; Staging; Case Summaries; Resectable Gastric Cancer; Evidence-Based Case Discussion; Locally Advanced Unresectable and Metastatic Gastric Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 8: Pancreatic Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries 327 $aResectable Pancreatic Adenocarcinoma 330 $ap> Praise for the First Edition:. ""As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information...by the time the book is [published]...it is outdated."" [Tumor Board Review] is fresh and just out of the oven...I haven't seen any book in oncology like this so far...I think my investment in this book was wise and worth it."" - Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center. Culling the knowledge and expertise of res 606 $aTumors$xDiagnosis 606 $aTumors$xThermotherapy 606 $aCancer$vHandbooks, manuals, etc 608 $aElectronic books. 615 0$aTumors$xDiagnosis. 615 0$aTumors$xThermotherapy. 615 0$aCancer 676 $a616.99/4 702 $aTodd$b Robert F.$cIII, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910464188103321 996 $aTumor board review$92460884 997 $aUNINA